Skip to main content
. 2019 Mar 20;13:521–527. doi: 10.2147/OPTH.S198648

Figure 1.

Figure 1

Effect of IFX+CsA combination therapy on the frequency of ocular inflammatory attacks. The frequency of ocular inflammatory attacks, assessed by the mean number of ocular attacks per 6-month period, decreases significantly following the initiation of IFX+CsA combination therapy (P=0.003, linear mixed models analysis). Data are presented as the mean±standard deviation.

Abbreviations: IFX, infliximab; CsA, cyclosporine; M, months.